Bridgeworth’s Novo Nordisk NVO Stock Holding History

Bridgeworth’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,050	Closed	-$24K	–	404
2018 Q2	$24K	Buy	+1,050	New	+$25K	0.01%	360

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bridgeworth's NVO Position: Q3 2018 in Review

Bridgeworth sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 1,050 shares — an estimated $24K sold.

Bridgeworth first reported a position in NVO in Q2 2018 and held it in 1 quarter. The position peaked at $24K in Q2 2018. 558 funds tracked by Wall St. Rank hold NVO as of Q3 2018.

Bridgeworth reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
Bridgeworth sold 1,050 Novo Nordisk shares in Q3 2018, an estimated $24K.
Bridgeworth first reported a position in Novo Nordisk in Q2 2018 and held it in 1 quarter.
Bridgeworth's Novo Nordisk position peaked at $24K in Q2 2018.
558 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.

Based on Bridgeworth's 13F filing for Q3 2018, filed 13 Nov 2018.